Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

710
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
710
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.0K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.0K
Infection01:20

Infection

10.6K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
10.6K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

89
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
89
Pneumonia IV: Management01:28

Pneumonia IV: Management

612
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
612
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

2.9K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Massive scabies outbreak in Rohingya refugee camps, Cox's Bazar: Epidemiology and impact of a mass drug administration (MDA) campaign - A retrospective study.

PLoS neglected tropical diseases·2026
Same author

Neutrophil-Membrane Biomimetic Hollow Mesoporous Silica Nanoparticles for Targeted Delivery of Imperatorin to Alleviate Cerebral Ischemia-Reperfusion Injury via Nrf2/ARE/Keap1 Pathway.

International journal of nanomedicine·2026
Same author

Seasonal Variation of Microplastic Contamination in Edible Bivalves (Green Mussels and Clams) from the Bay of Bengal Coast, Bangladesh.

Environmental monitoring and assessment·2026
Same author

Drought-induced shifts in soil microbial communities and carbon dynamics in agricultural and forest soils of Bangladesh.

3 Biotech·2026
Same author

Burkholderia cepacia complex (Bcc) in goats: First report in Bangladesh.

PloS one·2026
Same author

Physics-based design and simulation of hollow-core anti-resonant fiber plasmonic sensors.

Scientific reports·2026

Related Experiment Video

Updated: Nov 30, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.1K

COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management.

Md Farhad Hossain1,2, Sharifa Hasana3, Abdullah Al Mamun2,3

  • 1Department of Physical Therapy, Graduate School of Inje University, Gimhae, South Korea.

Frontiers in Pharmacology
|November 12, 2020
PubMed
Summary

The COVID-19 pandemic, caused by SARS-CoV-2, presents global health and economic challenges with unclear pathogenesis and no definitive treatment. This review explores therapeutic strategies to combat the virus.

Keywords:
Middle East respiratory syndrome coronaviruscoronaviruscoronavirus disease 2019severe acute respiratory syndrome coronavirus-2therapeutic interventionstransmission

More Related Videos

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

30.6K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.6K

Related Experiment Videos

Last Updated: Nov 30, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.1K
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

30.6K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.6K

Area of Science:

  • Virology
  • Epidemiology
  • Public Health

Background:

  • The emergence of coronavirus disease 2019 (COVID-19) in late 2019, caused by the novel SARS-CoV-2, has led to a global health crisis.
  • COVID-19 poses significant public health concerns and economic threats worldwide.
  • The pathogenesis of SARS-CoV-2 remains unclear, and effective treatments are lacking, necessitating urgent research into control methods.

Purpose of the Study:

  • To investigate the etiology, epidemiology, symptoms, and transmission routes of the novel coronavirus (SARS-CoV-2).
  • To review and summarize current therapeutic interventions for COVID-19.
  • To suggest potential antiviral treatments, immune-enhancing therapies, and supplements for managing SARS-CoV and MERS-CoV.

Main Methods:

  • Literature review of scientific publications on COVID-19, SARS-CoV, and MERS-CoV.
  • Analysis of epidemiological data, clinical symptoms, and transmission dynamics.
  • Synthesis of information on existing and potential therapeutic strategies.

Main Results:

  • The review details the origins, spread, and clinical manifestations of COVID-19.
  • Various therapeutic approaches, including antiviral agents and immune modulators, are discussed.
  • The study highlights the need for effective treatments targeting viral replication.

Conclusions:

  • Understanding the etiology and transmission of SARS-CoV-2 is critical for public health.
  • Further research into antiviral treatments and immune-boosting strategies is essential.
  • Developing effective interventions is crucial to mitigate the impact of COVID-19 and future coronavirus outbreaks.